Annual Operating Profit
-$71.79 M
+$20.95 M+22.59%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual operating income is -$71.79 million, with the most recent change of +$20.95 million (+22.59%) on December 31, 2023.
- During the last 3 years, EIGR annual operating profit has fallen by -$9.64 million (-15.51%).
- EIGR annual operating profit is now -3205.06% below its all-time high of -$2.17 million, reached on December 1, 2011.
Performance
EIGR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$12.61 M
+$4.31 M+25.48%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly operating income is -$12.61 million, with the most recent change of +$4.31 million (+25.48%) on December 31, 2023.
- Over the past year, EIGR quarterly operating profit has increased by +$11.86 million (+48.45%).
- EIGR quarterly operating profit is now -164.39% below its all-time high of $19.59 million, reached on December 31, 2015.
Performance
EIGR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$71.79 M
+$11.86 M+14.18%
December 31, 2023
Summary
- As of February 12, 2025, EIGR TTM operating income is -$71.79 million, with the most recent change of +$11.86 million (+14.18%) on December 31, 2023.
- Over the past year, EIGR TTM operating profit has increased by +$20.95 million (+22.59%).
- EIGR TTM operating profit is now -1967.57% below its all-time high of -$3.47 million, reached on March 31, 2013.
Performance
EIGR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EIGR Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.6% | +48.5% | +22.6% |
| 3 y3 years | -15.5% | +29.8% | -15.5% |
| 5 y5 years | -40.6% | +21.6% | -4.2% |
EIGR Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.6% | at high | +52.2% | at high | +23.0% |
| 5 y | 5-year | -15.5% | +22.6% | at high | +52.2% | -18.3% | +23.0% |
| alltime | all time | -3205.1% | +22.6% | -164.4% | +52.2% | -1967.6% | +23.0% |
Eiger BioPharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$71.79 M(-22.6%) | -$12.61 M(-25.5%) | -$71.79 M(-14.2%) |
| Sep 2023 | - | -$16.93 M(-15.3%) | -$83.64 M(-10.1%) |
| Jun 2023 | - | -$19.98 M(-10.3%) | -$93.08 M(-0.1%) |
| Mar 2023 | - | -$22.26 M(-9.0%) | -$93.18 M(+0.5%) |
| Dec 2022 | -$92.74 M(+20.5%) | -$24.47 M(-7.2%) | -$92.74 M(+4.0%) |
| Sep 2022 | - | -$26.37 M(+31.3%) | -$89.18 M(+5.3%) |
| Jun 2022 | - | -$20.08 M(-8.0%) | -$84.67 M(+2.1%) |
| Mar 2022 | - | -$21.82 M(+4.3%) | -$82.95 M(+7.8%) |
| Dec 2021 | -$76.94 M(+23.8%) | -$20.91 M(-4.3%) | -$76.94 M(+4.0%) |
| Sep 2021 | - | -$21.85 M(+19.0%) | -$73.99 M(+10.5%) |
| Jun 2021 | - | -$18.36 M(+16.1%) | -$66.97 M(+5.9%) |
| Mar 2021 | - | -$15.81 M(-12.0%) | -$63.24 M(+1.8%) |
| Dec 2020 | -$62.15 M(-9.8%) | -$17.96 M(+21.1%) | -$62.15 M(+2.4%) |
| Sep 2020 | - | -$14.84 M(+1.4%) | -$60.70 M(-5.4%) |
| Jun 2020 | - | -$14.63 M(-0.6%) | -$64.17 M(-3.8%) |
| Mar 2020 | - | -$14.72 M(-10.8%) | -$66.70 M(-3.2%) |
| Dec 2019 | -$68.90 M(+35.0%) | -$16.51 M(-9.8%) | -$68.90 M(+0.6%) |
| Sep 2019 | - | -$18.31 M(+6.7%) | -$68.48 M(+2.2%) |
| Jun 2019 | - | -$17.16 M(+1.4%) | -$67.02 M(+12.7%) |
| Mar 2019 | - | -$16.93 M(+5.2%) | -$59.47 M(+16.5%) |
| Dec 2018 | -$51.05 M | -$16.09 M(-4.4%) | -$51.05 M(+12.1%) |
| Sep 2018 | - | -$16.84 M(+75.2%) | -$45.54 M(+21.2%) |
| Jun 2018 | - | -$9.61 M(+13.0%) | -$37.57 M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$8.51 M(-19.6%) | -$39.04 M(-6.0%) |
| Dec 2017 | -$41.52 M(-10.0%) | -$10.59 M(+19.3%) | -$41.52 M(-5.3%) |
| Sep 2017 | - | -$8.87 M(-19.9%) | -$43.84 M(-5.3%) |
| Jun 2017 | - | -$11.08 M(+0.8%) | -$46.31 M(-4.4%) |
| Mar 2017 | - | -$10.99 M(-14.9%) | -$48.43 M(+5.0%) |
| Dec 2016 | -$46.12 M(+255.5%) | -$12.91 M(+13.9%) | -$46.12 M(+238.6%) |
| Sep 2016 | - | -$11.34 M(-14.1%) | -$13.62 M(+145.2%) |
| Jun 2016 | - | -$13.20 M(+52.1%) | -$5.56 M(+3.8%) |
| Mar 2016 | - | -$8.68 M(-144.3%) | -$5.35 M(-58.7%) |
| Dec 2015 | -$12.97 M(-60.7%) | $19.59 M(-698.9%) | -$12.97 M(-70.2%) |
| Sep 2015 | - | -$3.27 M(-74.8%) | -$43.52 M(-10.0%) |
| Jun 2015 | - | -$12.99 M(-20.3%) | -$48.38 M(+14.1%) |
| Mar 2015 | - | -$16.30 M(+48.7%) | -$42.39 M(+28.4%) |
| Dec 2014 | -$33.02 M(+65.4%) | -$10.96 M(+34.8%) | -$33.02 M(+17.8%) |
| Sep 2014 | - | -$8.13 M(+16.1%) | -$28.04 M(+10.3%) |
| Jun 2014 | - | -$7.00 M(+1.2%) | -$25.43 M(+8.6%) |
| Mar 2014 | - | -$6.92 M(+15.8%) | -$23.42 M(+17.3%) |
| Dec 2013 | -$19.96 M(+25.2%) | -$5.98 M(+8.2%) | -$19.96 M(+42.7%) |
| Sep 2013 | - | -$5.52 M(+10.6%) | -$13.99 M(+65.3%) |
| Jun 2013 | - | -$4.99 M(+43.8%) | -$8.46 M(+143.8%) |
| Mar 2013 | - | -$3.47 M | -$3.47 M |
| Dec 2012 | -$15.95 M(+634.1%) | - | - |
| Dec 2011 | -$2.17 M(-64.0%) | - | - |
| Jun 2011 | -$6.03 M | - | - |
FAQ
- What is Eiger BioPharmaceuticals annual operating income?
- What is the all time high annual operating profit for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual operating profit year-on-year change?
- What is Eiger BioPharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly operating profit year-on-year change?
- What is Eiger BioPharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals TTM operating profit year-on-year change?
What is Eiger BioPharmaceuticals annual operating income?
The current annual operating profit of EIGR is -$71.79 M
What is the all time high annual operating profit for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual operating income is -$2.17 M
What is Eiger BioPharmaceuticals annual operating profit year-on-year change?
Over the past year, EIGR annual operating income has changed by +$20.95 M (+22.59%)
What is Eiger BioPharmaceuticals quarterly operating income?
The current quarterly operating profit of EIGR is -$12.61 M
What is the all time high quarterly operating profit for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly operating income is $19.59 M
What is Eiger BioPharmaceuticals quarterly operating profit year-on-year change?
Over the past year, EIGR quarterly operating income has changed by +$11.86 M (+48.45%)
What is Eiger BioPharmaceuticals TTM operating income?
The current TTM operating profit of EIGR is -$71.79 M
What is the all time high TTM operating profit for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high TTM operating income is -$3.47 M
What is Eiger BioPharmaceuticals TTM operating profit year-on-year change?
Over the past year, EIGR TTM operating income has changed by +$20.95 M (+22.59%)